The Latest Cardiac and Vascular News
October 15, 2020 New data suggest that PCI guided by iFR co-registered on the angiogram can improve outcomes and reduce angina for patients more effectively than treatment guided by angiography alone Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the one-year results […]
October 15, 2020 Turnkey solution for newly-built hospital combines latest innovations in enterprise diagnostic imaging, connected care and informatics, as well as service, maintenance and financing Amsterdam, the Netherlands and Jakarta, Indonesia – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Mandaya Royal Hospital Puri today announced a seven-year strategic […]
FDA, industry, and patient advocacy groups join effort to advance effective cardiac screening DURHAM, N.C.–(BUSINESS WIRE)–The Cardiac Safety Research Consortium (CSRC) announces the establishment of a first-in-kind national database of pediatric cardiac screening information aimed at advancing the ability to discover potentially dangerous pediatric cardiac conditions and preventing sudden cardiac […]
Bold New Program Enhances Patient Care While Decreasing Costly Hospital Readmissions and Gaps in Care EDISON, N.J.–(BUSINESS WIRE)–Spring Hills today announced that it has launched a new comprehensive cardiac program at three of its post-acute care facilities in New Jersey. Currently accepting patients in Livingston, Wayne and Woodbury, the program features […]
CARLSBAD, Calif.–(BUSINESS WIRE)–Ra Medical Systems, Inc. (NYSE: RMED), a medical device company focused on commercializing excimer laser systems to treat vascular and dermatological diseases, announces enrollment of the 10th subject in its pivotal clinical trial to evaluate the safety and effectiveness of the DABRA excimer laser system as an atherectomy device […]
DANVERS, Mass.–(BUSINESS WIRE)–Abiomed (NASDAQ: ABMD) announces new PROTECT III study data that demonstrates reduced rates of MACCE (composite of death, stroke, myocardial infarction and repeat procedures) when Impella is used to achieve a more complete revascularization in a single setting for high-risk percutaneous coronary intervention (PCI) patients. PROTECT III is an ongoing, prospective, […]
Tenax gains developmental and commercial rights for a fully-developed oral levosimendan formulation in the U.S. and Canada Oral formulation expected to be used in upcoming Phase 3 registration trial MORRISVILLE, N.C.–(BUSINESS WIRE)–Tenax Therapeutics, Inc. (Nasdaq: TENX), a specialty pharmaceutical company focused on identifying, developing, and commercializing products for the critical […]
Safety and Tolerability Established Good and Excellent Functional Outcome Increased YONGIN, South Korea–(BUSINESS WIRE)–GNT Pharma Inc. today reports positive top-line results from a phase II, double-blind, randomized, placebo-controlled, multi-center study assessing the safety and efficacy of nelonemdaz in acute ischemic stroke patients treated with endovascular thrombectomy within 8 hours of symptom […]
First European Commercial Case Completed at East & North Hertfordshire Hospital in England IRVINE, Calif.–(BUSINESS WIRE)—Oct 15, 2020–Furthering its mission to transform the treatment of aortic disorders, Endologix LLC today announced the first implant of its ALTO™ Abdominal Stent Graft, commencing the European commercial release of the recently CE Mark […]
San Antonio, TX – Bluegrass Vascular Technologies (Bluegrass Vascular), a private medical technology company focused on innovating lifesaving devices and methods for vascular access procedures, announced today the publication of the results from the company’s prospective, multicenter SAVE (Surfacer® System to Facilitate Access in VEnous Occlusions) Registry in the Journal of Vascular and Interventional Radiology (JVIR). […]
